Identity
Synovathera (Syn-Ova-Thera) draws its name from the classical roots of Latin and Greek, reflecting the historical foundation of medicine. "Syn" signifies synergy and our collaborative approach to integrating scientific innovation. "Ova" symbolizes new beginnings in medical breakthroughs, while "Thera," from therapeutics, highlights our focus on impactful medical treatments.
Leadership Team
Our leadership team offers over 60 years of combined expertise in product development and commercialization, specializing in Oncology, Rare Diseases, CNS, Cardiovascular, Anesthesiology, and Pain Management.
With strengths in regulatory affairs, market access, marketing, sales, and compliance, we customize go-to-market strategies tailored to each drug and therapeutic area.
Working closely with clinical and key opinion leaders, we support Health Canada submissions and foster acceptance within the medical community to ensure impactful, successful product launches.
Mission
Accelerated Impact
Synovathera expedites the launch of transformative therapies through efficient, results-oriented solutions. We integrate AI-driven insights with strategic expertise to foster growth and sustainable success. By partnering with leaders in government, academia, industry, and investment, we enable Canadians to access clinical solutions for unmet needs and empower our strategic partners to excel in a competitive market.
- Accelerated Market Access: Rapidly introduce your products to the Canadian market.
- Cost-Effective Solutions: Streamline commercialization while minimizing internal costs.
- Risk Management: Mitigate risks in product development and marketing.
- Geographic Reach: Seamlessly expand into new regions with local expertise.
- Maximized Impact: Reach the right audience for optimal success.
- Faster Time to Market: Expedite commercialization with proven, effective strategies.
